Screener
Aflac AFL Dental/vision — Issuances
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Aflac in its filing.
Tagged under the XBRL concept us-gaap:LiabilityForFuturePolicyBenefitExpectedFuturePolicyBenefitIssuance.
The source filing: Aflac’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 9:18 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054618
| (In millions) | Aflac Japan / Cancer | Aflac Japan / Medicaland Other Health | Aflac Japan / Life Insurance | Aflac Japan / Other | Aflac U.S. / Accident | Aflac U.S. / Disability | Aflac U.S. / Critical Care | Aflac U.S. / Hospital Indemnity | Aflac U.S. / Dental/Vision | Aflac U.S. / Life Insurance | Aflac U.S. / Other |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Effect of changes in cash flow assumptions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effect of actual variances from expected experience | (277) | (187) | (46) | (13) | (40) | 9 | (46) | (12) | (4) | (39) | (48) |
| Adjusted beginning of period balance | 36,161 | 21,792 | 25,670 | 4,745 | 3,308 | 2,410 | 11,766 | 2,059 | 454 | 2,249 | 2,256 |
| Issuances | 428 | 169 | 169 | 3 | 174 | 186 | 300 | 136 | 24 | 182 | 595 |
| Interest accrual | 602 | 265 | 265 | 43 | 69 | 50 | 256 | 44 | 10 | 48 | 73 |
| Benefit payments | (1,264) | (485) | (1,080) | (108) | (251) | (238) | (489) | (159) | (30) | (57) | (133) |
| Foreign currency translation | (1,293) | (782) | (903) | (168) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Aflac's dental/vision — issuances?
- Aflac (AFL) reported dental/vision — issuances of $10M in Q2 2026.
- How has Aflac's dental/vision — issuances changed year-over-year?
- Aflac's dental/vision — issuances decreased by 28.6% year-over-year, from $14M to $10M.
- What is the long-term trend for Aflac's dental/vision — issuances?
- Over 4 years (2021 to 2025), Aflac's dental/vision — issuances has grown at a 5.7% compound annual growth rate (CAGR), from $40M to $50M.
- What does dental/vision — issuances mean?
- This metric tracks the volume of new dental and vision insurance policies issued during the reporting period. It is a primary indicator of top-line growth and market penetration for this specific product segment. High issuance rates demonstrate successful sales distribution and product-market fit.
Ask your AI about Aflac's dental/vision — issuances.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude